Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis-Reference-Cited by-同舟云学术

Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis

Published:2011-02 Issue:2-3 Volume:60 Page:223-234
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Scullion G.A.,Kendall D.A.,Marsden C.A.,Sunter D.,Pardon M.-C.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference66 articles.

1. Changes in the brain catecholamines in patients with dementia of Alzheimer type;Adolfsson;Br. J. Psychiatr.,1979

2. Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions;Aguilar-Valles;Neuroendocrinology,2005

3. Radial maze performance and open-field behaviours in aged C57BL/6 mice: further evidence for preserved cognitive abilities during senescence;Ammassari-Teule;Physiol. Behav.,1994

4. Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine;Arnsten;Neurobiol. Aging,1993

5. Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates;Arnsten;Science,1985

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct binding conformations of epinephrine with α- and β-adrenergic receptors;Experimental & Molecular Medicine;2024-09-02

2. The Role of the Adrenergic System in Neurodegeneration and Oxidative Stress-Induced Damage to the Brain;Neurochemical Journal;2023-12

3. Can chronic therapeutic drug use by the elderly affect Alzheimer’s disease risk and rate of progression?;Exploration of Neuroprotective Therapy;2023-02-27

4. Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease;Frontiers in Aging Neuroscience;2022-10-04

5. Cognitive Impairment in Alzheimer’s and Metabolic Diseases: A Catecholaminergic Hypothesis;Neuroscience;2022-08